ReP USP - Resultado da busca

Trabalho de evento-resumo
Cannabidiol modulates L-DOPA induced dyskinesia via CB1 receptor (2015)
Pereira, M. S.; Silva, C.; Guimarães, Francisco Silveira; Del Bel, Elaine Aparecida
Fonte: Abstracts. Nome do evento: Annual Meeting of the Society for Neuroscience. Unidades: FMRP, FORP
Assuntos: CANABINOIDES, DISCINESIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, M. S. et al. Cannabidiol modulates L-DOPA induced dyskinesia via CB1 receptor. 2015, Anais.. Chicago: Society for Neuroscience, 2015. . Acesso em: 13 nov. 2024.
APA
Pereira, M. S., Silva, C., Guimarães, F. S., & Del Bel, E. A. (2015). Cannabidiol modulates L-DOPA induced dyskinesia via CB1 receptor. In Abstracts. Chicago: Society for Neuroscience.
NLM
Pereira MS, Silva C, Guimarães FS, Del Bel EA. Cannabidiol modulates L-DOPA induced dyskinesia via CB1 receptor. Abstracts. 2015 ;[citado 2024 nov. 13 ]
Vancouver
Pereira MS, Silva C, Guimarães FS, Del Bel EA. Cannabidiol modulates L-DOPA induced dyskinesia via CB1 receptor. Abstracts. 2015 ;[citado 2024 nov. 13 ]
Trabalho de evento-resumo
Cannabidiol reduces LPS-induced activation and oxidative stress in primary microglial culture via PPARgamma receptor (2015)
Sonego, A. B.; Sepulveda-Diaz, J. E.; Michel, P. P.; Del Bel, Elaine Aparecida; Guimarães, Francisco Silveira; Raisman-Vozari, R.
Fonte: Abstracts. Nome do evento: Annual Meeting of the Society for Neuroscience. Unidades: FMRP, FORP
Assuntos: CANABINOIDES, RECEPTORES, MODELOS ANIMAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SONEGO, A. B. et al. Cannabidiol reduces LPS-induced activation and oxidative stress in primary microglial culture via PPARgamma receptor. 2015, Anais.. Chicago: Society for Neuroscience, 2015. . Acesso em: 13 nov. 2024.
APA
Sonego, A. B., Sepulveda-Diaz, J. E., Michel, P. P., Del Bel, E. A., Guimarães, F. S., & Raisman-Vozari, R. (2015). Cannabidiol reduces LPS-induced activation and oxidative stress in primary microglial culture via PPARgamma receptor. In Abstracts. Chicago: Society for Neuroscience.
NLM
Sonego AB, Sepulveda-Diaz JE, Michel PP, Del Bel EA, Guimarães FS, Raisman-Vozari R. Cannabidiol reduces LPS-induced activation and oxidative stress in primary microglial culture via PPARgamma receptor. Abstracts. 2015 ;[citado 2024 nov. 13 ]
Vancouver
Sonego AB, Sepulveda-Diaz JE, Michel PP, Del Bel EA, Guimarães FS, Raisman-Vozari R. Cannabidiol reduces LPS-induced activation and oxidative stress in primary microglial culture via PPARgamma receptor. Abstracts. 2015 ;[citado 2024 nov. 13 ]
Artigo de periodico
Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension (2015)
Guimarães, Danielle A.; Rizzi, Ellen; Ceron, Carla S.; Martins-Oliveira, Alisson; Gerlach, Raquel Fernanda; Shiva, Sruti; Tanus-Santos, José Eduardo
Fonte: Redox Biology. Unidades: FMRP, FORP
Assuntos: HIPERTENSÃO, ÓXIDO NÍTRICO, METALOPROTEINASES, FÁRMACOS (SISTEMA CARDIOVASCULAR)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIMARÃES, Danielle A. et al. Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension. Redox Biology, v. 6, p. 386-395, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.redox.2015.08.017. Acesso em: 13 nov. 2024.
APA
Guimarães, D. A., Rizzi, E., Ceron, C. S., Martins-Oliveira, A., Gerlach, R. F., Shiva, S., & Tanus-Santos, J. E. (2015). Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension. Redox Biology, 6, 386-395. doi:10.1016/j.redox.2015.08.017
NLM
Guimarães DA, Rizzi E, Ceron CS, Martins-Oliveira A, Gerlach RF, Shiva S, Tanus-Santos JE. Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension [Internet]. Redox Biology. 2015 ; 6 386-395.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.redox.2015.08.017
Vancouver
Guimarães DA, Rizzi E, Ceron CS, Martins-Oliveira A, Gerlach RF, Shiva S, Tanus-Santos JE. Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension [Internet]. Redox Biology. 2015 ; 6 386-395.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.redox.2015.08.017
Artigo de periodico
Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine (2015)
Pedrazzi, João Francisco Cordeiro; Issy, A. C.; Gomes, F. V.; Guimarães, Francisco Silveira; Del Bel, Elaine Aparecida
Fonte: Psychopharmacology. Unidades: FMRP, FORP
Assuntos: CANABINOIDES, ESQUIZOFRENIA, ANTIPSICÓTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEDRAZZI, João Francisco Cordeiro et al. Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine. Psychopharmacology, v. 232, n. 16, p. 3057-3065, 2015Tradução . . Disponível em: https://doi.org/10.1007/s00213-015-3945-7. Acesso em: 13 nov. 2024.
APA
Pedrazzi, J. F. C., Issy, A. C., Gomes, F. V., Guimarães, F. S., & Del Bel, E. A. (2015). Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine. Psychopharmacology, 232( 16), 3057-3065. doi:10.1007/s00213-015-3945-7
NLM
Pedrazzi JFC, Issy AC, Gomes FV, Guimarães FS, Del Bel EA. Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine [Internet]. Psychopharmacology. 2015 ; 232( 16): 3057-3065.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s00213-015-3945-7
Vancouver
Pedrazzi JFC, Issy AC, Gomes FV, Guimarães FS, Del Bel EA. Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine [Internet]. Psychopharmacology. 2015 ; 232( 16): 3057-3065.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s00213-015-3945-7
Artigo de periodico
Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol (2015)
Gomes, Felipe V.; Llorente, Ricardo; Del Bel, Elaine Aparecida; Viveros, Maria-Paz; López-Gallardo, Meritxell; Guimarães, Francisco Silveira
Fonte: Schizophrenia Research. Unidades: FORP, FMRP
Assuntos: CANNABIS (COMPONENTES), ASTRÓCITOS, ANTIPSICÓTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Felipe V. et al. Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol. Schizophrenia Research, v. 164, n. 1-3, p. 155-163, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.schres.2015.01.015. Acesso em: 13 nov. 2024.
APA
Gomes, F. V., Llorente, R., Del Bel, E. A., Viveros, M. -P., López-Gallardo, M., & Guimarães, F. S. (2015). Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol. Schizophrenia Research, 164( 1-3), 155-163. doi:10.1016/j.schres.2015.01.015
NLM
Gomes FV, Llorente R, Del Bel EA, Viveros M-P, López-Gallardo M, Guimarães FS. Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol [Internet]. Schizophrenia Research. 2015 ; 164( 1-3): 155-163.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.schres.2015.01.015
Vancouver
Gomes FV, Llorente R, Del Bel EA, Viveros M-P, López-Gallardo M, Guimarães FS. Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol [Internet]. Schizophrenia Research. 2015 ; 164( 1-3): 155-163.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.schres.2015.01.015
Artigo de periodico
The nuclear factor kappaB inhibitor pyrrolidine dithiocarbamate prevents cardiac remodelling and matrix metalloproteinase-2 up-regulation in renovascular hypertension (2015)
Cau, Stefany B. A.; Guimarães, Danielle Aparecida; Rizzi, Elen; Ceron, Carla S.; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo
Fonte: Basic and Clinical Pharmacology and Toxicology. Unidades: FMRP, FORP
Assuntos: HIPERTENSÃO, METALOPROTEINASES, RECEPTORES IMUNOLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAU, Stefany B. A. et al. The nuclear factor kappaB inhibitor pyrrolidine dithiocarbamate prevents cardiac remodelling and matrix metalloproteinase-2 up-regulation in renovascular hypertension. Basic and Clinical Pharmacology and Toxicology, v. 117, n. 4, p. 234-241, 2015Tradução . . Disponível em: https://doi.org/10.1111/bcpt.12400. Acesso em: 13 nov. 2024.
APA
Cau, S. B. A., Guimarães, D. A., Rizzi, E., Ceron, C. S., Gerlach, R. F., & Tanus-Santos, J. E. (2015). The nuclear factor kappaB inhibitor pyrrolidine dithiocarbamate prevents cardiac remodelling and matrix metalloproteinase-2 up-regulation in renovascular hypertension. Basic and Clinical Pharmacology and Toxicology, 117( 4), 234-241. doi:10.1111/bcpt.12400
NLM
Cau SBA, Guimarães DA, Rizzi E, Ceron CS, Gerlach RF, Tanus-Santos JE. The nuclear factor kappaB inhibitor pyrrolidine dithiocarbamate prevents cardiac remodelling and matrix metalloproteinase-2 up-regulation in renovascular hypertension [Internet]. Basic and Clinical Pharmacology and Toxicology. 2015 ; 117( 4): 234-241.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1111/bcpt.12400
Vancouver
Cau SBA, Guimarães DA, Rizzi E, Ceron CS, Gerlach RF, Tanus-Santos JE. The nuclear factor kappaB inhibitor pyrrolidine dithiocarbamate prevents cardiac remodelling and matrix metalloproteinase-2 up-regulation in renovascular hypertension [Internet]. Basic and Clinical Pharmacology and Toxicology. 2015 ; 117( 4): 234-241.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1111/bcpt.12400

Unidades USP

ReP

Filtros

Autores

Assuntos

Indexado em